-
$0
0.0% of portfolio
-
Q1 2025
Reduced 26.75%
Artius Ii Acquisition Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 40.58%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 214.37%
Black Hawk Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.32%
Black Hawk Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.1%
Black Spade Acquisition Ii C
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 300.0%
Bleichroeder Acquisition Cor
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 5.9%
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 81.97%
Alphavest Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 56.47%
Alphavest Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 1.55%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 35.68%
Andretti Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q4 2024
New
Andretti Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 7.56%
-
$0
0.0% of portfolio
-
Q1 2025
Added 102.04%
Archimedes Tech Spac Partner
-
$0
0.0% of portfolio
-
Q1 2025
New
A Spac Iii Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
New
Drugs Made In Amer Acqutn CO
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 98.84%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 29.53%
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.0%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 16.72%
Haymaker Acquisition Corp Iv
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.92%
Haymaker Acquisition Corp Iv
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.14%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 17.6%
-
$0
0.0% of portfolio
-
Q1 2025
Added 53.13%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 2.58%
Gesher Acquisition Corp. Ii
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.38%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.73%
$0
$19,000
0.0% of portfolio
654,647
Q2 2023
Reduced 0.63%
$0
$45,000
0.0% of portfolio
654,647
Q2 2023
Reduced 0.63%
Gp Act Iii Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.18%
Gp Act Iii Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 5.85%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.8%
Hennessy Cap Invt Corp Vii
-
$0
0.0% of portfolio
-
Q1 2025
New
Hennessy Cap Invt Corp Vii
-
$0
0.0% of portfolio
-
Q1 2025
New
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.03%
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.98%
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.03%
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 0.53%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 60.0%
Jackson Acquisition CO Ii
-
$0
0.0% of portfolio
-
Q1 2025
New
Jackson Acquisition CO Ii
-
$0
0.0% of portfolio
-
Q1 2025
New